RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Enliven Therapeutics Net Income 2024

Enliven Therapeutics Net Income

-110.42 M USD

Enliven Therapeutics Dividend yield

Ticker

ELVN

ISIN

US29337E1029

In 2024, Enliven Therapeutics's profit amounted to -110.42 M USD, a 54.25% increase from the -71.58 M USD profit recorded in the previous year.

The Enliven Therapeutics Net Income history

YEARNET INCOME (undefined USD)
2026e-157.38
2025e-135.31
2024e-110.42
2023-71.58
20221.49
2021-51.38
2020-49.22
2019-23.46
2018-11.34
20170.22

Enliven Therapeutics Aktienanalyse

What does Enliven Therapeutics do?

Enliven Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Enliven Therapeutics's Profit Margins

The profit margins of Enliven Therapeutics represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Enliven Therapeutics's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Enliven Therapeutics's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Enliven Therapeutics's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Enliven Therapeutics’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Enliven Therapeutics Stock

How much profit has Enliven Therapeutics made this year?

Enliven Therapeutics has made -110.42 M USD this year.

How has the profit developed compared to last year?

The profit has increased by 54.25% compared to last year increased

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Enliven Therapeutics publish its earnings?

Enliven Therapeutics publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Enliven Therapeutics?

The profits of Enliven Therapeutics are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Enliven Therapeutics?

You can learn more about the earnings of Enliven Therapeutics by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Enliven Therapeutics pay?

Over the past 12 months, Enliven Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Enliven Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Enliven Therapeutics?

The current dividend yield of Enliven Therapeutics is .

When does Enliven Therapeutics pay dividends?

Enliven Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Enliven Therapeutics?

Enliven Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Enliven Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Enliven Therapeutics located?

Enliven Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Enliven Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Enliven Therapeutics from 6/2/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/2/2024.

When did Enliven Therapeutics pay the last dividend?

The last dividend was paid out on 6/2/2024.

What was the dividend of Enliven Therapeutics in the year 2023?

In the year 2023, Enliven Therapeutics distributed 0 USD as dividends.

In which currency does Enliven Therapeutics pay out the dividend?

The dividends of Enliven Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Enliven Therapeutics

Our stock analysis for Enliven Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Enliven Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.